Insights
Resources & News
New Models of Commercial Excellence in the Pharmaceutical Industry: Sales Excellence, Customer Excellence and New Customer-Focused Business Models
The commercial operating model traditionally used by the pharmaceutical industry is under growing strain. Financial pressure, regulatory changes and increasing number of decision-makers in the healthcare sector are among the factors calling into question the...
Here and There: For the life sciences, Switzerland is particularly attractive
In order to remain competitive today, multinational companies (MNCs) have several options, including choosing the most advantageous location economically for their various operations. The strategic decision regarding where to locate the headquarters is one of the key...
Trends in European Healthcare: How to create value in a dynamic environment
Health care has always been an issue of great significance. But never before has it been more important than today: With economies shifting from an industrial to a more service-orientated approach, this sector is allocated a very high percentage of Gross Domestic...
Commercial excellence in the pharmaceutical industry: Delivering superior value to your customers in challenging times
These are challenging times for the pharmaceutical industry. In their bid to ensure continuous sales growth and satisfy shareholders, companies must completely rethink their conventional approach to marketing and sales – and strive for a whole new level of commercial...
On demand: Pressure to cut costs is prompting pharma to outsource a variety of marketing services to third parties
Pharma can already choose from a wide variety of outsourced marketing services. Companies have begun to establish partnerships with various vendors offering traditional (onshore) or nearshore and offshore outsourcing services. The industry already outsources ongoing,...
Levers for change: The influence of new stakeholders over medicine prices in Germany is escalating
Levers from healthcare reforms are located throughout the decision making process to determine whether a drug reaches the patient – beginning with drug approval and ending with patient compliance. Previous reforms focused on the levers towards the end of this process...
What advantages do DRGs bring to Swiss hospitals? DRGs in Switzerland – experiences, expectations and conclusions from the perspective of service providers
Although critical voices repeatedly complain about the increasing influence of basic economic concepts such as cost savings, efficiency improvements and rationalization in the Swiss healthcare system, more and more Swiss healthcare insurance premium and tax payers are...
How do German hospitals live with DRGs? The German G-DRG system, background and experiences from the perspective of service providers
The introduction of Diagnosis-Related Groups (DRGs) requires a thorough review and adjustment of organizational structures and processes within hospitals. Hospitals need to create conditions that enable a successful positioning on the market under DRG conditions, such...
Marketing Masterclass: Salesforce Effectiveness: Is the Pharmaceutical Industry going in the Right Direction?
As the healthcare environment for the pharmaceutical industry is undergoing major changes, salesforce effectiveness replaces the traditional ‘size sells paradigm’. Consequently, pharmaceutical companies are being forced to optimise both their bottom and top line. This...
Insights
Weekly Free Business Resources
If you want to receive weekly business resources and news, please subscribe to our Insights blog.
Almasan AG
The right support for the pharma/ biotech, medtech/ diagnostics, life sciences and healthcare sectors at the right time in the right way: Advisory, Interim Management and Contracting/ Outsourcing.